Revelation Biosciences Inc [NASDAQ: REVB] plunged by -$0.01 during the normal trading session on Thursday and reaching a high of $0.8 during the day while it closed the day at $0.76.
Revelation Biosciences Inc stock has also loss -7.32% of its value over the past 7 days. However, REVB stock has declined by -71.54% in the 3 months of the year. Over the past six months meanwhile, it has lost -87.66% and lost -97.46% year-on date.
The market cap for REVB stock reached $1.54 million, with 2.03 million shares outstanding and 2.03 million shares in the current float. Compared to the average trading volume of 1.09M shares, REVB reached a trading volume of 367593 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Revelation Biosciences Inc [REVB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for REVB shares is $331.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on REVB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.25, with the Price to Cash per share for the same quarter was set at 1.83.
REVB stock trade performance evaluation
Revelation Biosciences Inc [REVB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.32. With this latest performance, REVB shares dropped by -15.62% in over the last four-week period, additionally sinking by -87.66% over the last 6 months – not to mention a drop of -89.70% in the past year of trading.
Revelation Biosciences Inc [REVB]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -154.33%, with Return on Assets sitting at -154.33%.
Earnings per share (EPS) analysis for Revelation Biosciences Inc [REVB] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for REVB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Revelation Biosciences Inc go to 72.37%.
Revelation Biosciences Inc [REVB]: Institutional Ownership
There are presently around $1.70%, or 1.74% of REVB stock, in the hands of institutional investors.
